RT Anthony DiGiorgio, DO, MHA (@DrDiGiorgio)This is a really bad thing.These jobs in healthcare aren’t nurses or doctors.They’re middle managers, billing specialists, and people whose sole job is to extract the maximum amount of government dollars for large hospital systems.They don’t make care better. In fact, they make it much worse. They harass the frontline workers, physicians and nurses, driving them to early exits from clinical medicine. They consider patients nothing more than widgets.Worst of all, t ...

Core Insights - P3 Health Partners Inc. reported its financial results for Q4 and full year 2025, indicating a strategic repositioning of the business and a clear path to profitability for 2026 with an expected $10 million adjusted EBITDA midpoint [1][2]. Financial Performance Fourth Quarter 2025 Results - Total revenue reached $384.8 million, up from $370.7 million in Q4 2024, with capitated revenue PMPM improving by 9% year-over-year to $1,060 [3]. - The company reported a net loss of $165.7 million compared to a net loss of $129.1 million in the same quarter of the previous year [3]. - Adjusted EBITDA loss was $76.1 million, worsening from a loss of $67.6 million in Q4 2024 [3]. Full-Year 2025 Results - Total revenue for the year was $1.46 billion, down from $1.50 billion in 2024, with capitated revenue PMPM improving by 5% year-over-year to $1,026 [3]. - The net loss for the year was $323.1 million, compared to a net loss of $310.4 million in 2024 [3]. - Adjusted EBITDA loss for the year was $161.3 million, an improvement from a loss of $167.2 million in 2024 [4]. 2026 Guidance - The company expects adjusted EBITDA to range from negative $20 million to positive $40 million, with a midpoint of $10 million, indicating a projected $170 million year-over-year improvement [4]. - At-risk membership is anticipated to be between 107,000 and 117,000, with total revenues expected to be between $1.5 billion and $1.7 billion [4]. Strategic Initiatives - The CEO highlighted the strengthening of contract economics and provider alignment as key factors in the company's progress, emphasizing a deliberate approach to growth that enhances long-term earnings potential [2]. - The company aims to improve its operational foundation and provider relationships to support its transition to profitability [2].

Core Insights - HCA Healthcare, Inc. is scheduled to hold its 1st Quarter 2026 Earnings Call on April 24, 2026, at 9:00 AM Central Time [1] - The company has been recognized as one of the 2026 World's Most Ethical Companies by Ethisphere, marking its 16th recognition in this category [3] - A total of 92 HCA Healthcare hospitals received the 2026 Patient Safety Excellence Award from Healthgrades, placing them in the top 10% of hospitals nationwide for patient safety [4] Group 1: Earnings Call - HCA Healthcare will conduct its 1Q 2026 Earnings Call on April 24, 2026, at 9:00 AM Central Time, available via live audio webcast [1] Group 2: Ethical Recognition - HCA Healthcare has been named one of the 2026 World's Most Ethical Companies by Ethisphere, recognized for its commitment to ethics, compliance, and governance practices [3] Group 3: Patient Safety Awards - 92 hospitals under HCA Healthcare have achieved the 2026 Patient Safety Excellence Award from Healthgrades, reflecting their dedication to safe, patient-centered care [4] Group 4: Upcoming Conferences - HCA Healthcare is scheduled to present at several healthcare conferences in March 2026, including the TD Cowen Health Care Conference and the Raymond James Institutional Investors Conference [5]

Company Overview - HCA Healthcare, Inc. is the largest hospital operator in the U.S., running a network of 190 hospitals and approximately 2,400 ambulatory care sites, excluding its operations in the UK [2] - The company provides a wide range of services including inpatient, emergency, surgical, diagnostic, intensive care, outpatient, and behavioral health services [2] Financial Performance - HCA has reduced its share count by 44% since the end of 2015, indicating a strong commitment to shareholder value [2] - The stock has reached new all-time highs recently but has experienced a pullback of nearly $50 without a specific reason, suggesting potential buying opportunities [2] Investment Sentiment - The stock has been positively viewed by analysts, with a recommendation to buy in increments at different price points ($500, $475, $450) to manage risk [1] - Despite the positive outlook for HCA, there are suggestions that certain AI stocks may offer greater upside potential with less downside risk [3]

Core Viewpoint - Community Health Systems (CYH) has experienced a decline in share price by approximately 14.8% since its last earnings report, underperforming the S&P 500 index [1][2] Financial Performance - In Q4, Community Health reported break-even earnings per share, surpassing the Zacks Consensus Estimate of a loss of 32 cents, and improved from a loss of 42 cents in the same quarter last year [3] - Net operating revenues for the quarter decreased by 4.9% year over year to $3.1 billion, missing the consensus estimate by 1.2% [3] - For the full year 2025, revenues were reported at $12.5 billion, a slight decline from $12.6 billion in the previous year, while adjusted operating income improved to $1.19 per share from an adjusted operating loss of $1.03 [5] - Full-year adjusted EBITDA decreased marginally to $1.52 billion from $1.54 billion in the previous year [5] Operational Metrics - Community Health operated 69 hospitals at the end of Q4, down from 76 in the prior year [6] - Patient days declined by 8.5% year over year, and the occupancy rate fell to 49.6% from 50.5% [6] - Adjusted admissions decreased by 6.8% year over year, with same-store admissions down by 0.3% [6] Expense Management - Total operating expenses in Q4 declined by 11.1% year over year to $2.7 billion, primarily due to lower supplies and other operating costs [7] - Net interest expense increased by 1.8% year over year to $222 million, but was lower than the estimate of $225.4 million [8] Cash Flow and Debt - As of December 31, 2025, Community Health had cash and cash equivalents of $260 million, significantly up from $37 million at the end of 2024 [9] - Long-term debt decreased to $10.4 billion from $11.4 billion at the end of 2024 [9] - Operating cash flows for the year were $543 million, an increase from $480 million in the previous year [10] Future Guidance - For 2026, the company anticipates net operating revenues between $11.6 billion and $12 billion, with adjusted EBITDA expected to range from $1.34 billion to $1.49 billion [11] - The projected bottom line for 2026 is expected to be between a loss of 60 cents and break-even [11] - Estimated net cash from operating activities for 2026 is between $600 million and $700 million, with capital expenditures anticipated to be between $350 million and $400 million [12] Market Sentiment - Recent estimates for Community Health Systems have trended upward, with a consensus estimate shift of 5.78% [13] - The company holds a strong Growth Score of A and an aggregate VGM Score of A, indicating favorable conditions for value investors [14] - Community Health Systems has a Zacks Rank of 2 (Buy), suggesting expectations for above-average returns in the coming months [15]

Farrer Park is exploring a sale of assets including a hospital, medical center and hotel in Singapore, according to sources https://t.co/SBS9vBuiiW ...

Group 1 - SBI Funds Management is preparing to file its draft red herring prospectus (DRHP) for an initial public offering (IPO) worth between ₹12,000-13,000 crore, which is over $1 billion [1][7] - The IPO is expected to be an offer for sale (OFS), allowing existing shareholders to reduce their stakes while raising growth capital for the business [2][7] - SBI Funds Management is a joint venture between State Bank of India, holding a 63% stake, and Amundi, which owns nearly 37%, with total assets exceeding ₹12.5 lakh crore [7] Group 2 - Manipal Hospitals, backed by Temasek, is estimated to file its DRHP for an IPO valued at ₹9,000-11,000 crore, expected to be submitted as early as this month [1][7] - The IPO for Manipal Hospitals is likely to include a mix of fresh equity issuance and an OFS component, facilitating partial exits for existing investors while raising capital for growth [2][7] - The investment banks involved in the SBI Funds issue include Bank of America, HSBC, and Kotak Mahindra Capital, among others [1][7]

Did you know that if healthc care was a country, it would be the fifth biggest emitter of greenhouse gases worldwide? I work as anesthesiologists. So I earn my money by making people fall asleep. So if you fall asleep during this talk, don't worry. That's just me being very good at my job. My work in anesthesia is often routine, sometimes even boring. But at times it gets really fast and stressful and many things happen and need to be tackled at once. Complications happen, errors happen, and sometimes, no m ...

Yonki Polo Garcia is fighting for her life at this hospital in Havana. The mother of two young boys has leukemia. Administering what in most places would be routine cancer treatments is almost impossible here.>> Garcia lives about 20 m away from the hospital, too far to walk. She tells me without fuel or affordable transportation, life has only gotten harder. We are fighting every day.She says my biggest fear is going to bed and not waking up next morning. This is a supply room where all of the medicine is ...

Summary of Community Health Systems (NYSE: CYH) FY Conference Call Company Overview - **Company**: Community Health Systems (CHS) - **Date of Conference**: March 17, 2026 - **Speakers**: CEO Kevin Hammons, CFO Jason Johnson Key Points Business Update - CHS is optimistic about its progress coming out of Q4 2025, having achieved free cash flow positive for the first time in several years and reduced leverage significantly [2][41] - The company has completed additional divestitures to improve free cash flow and lower leverage further [2][41] Strategic Vision and Priorities - CHS aims to enhance the healthcare experience for patients, communities, and employees, focusing on five top priorities: quality improvement, patient experience, physician experience, and employee satisfaction [3][4] Financial Guidance - Guidance for 2026 includes a projected 5% increase in net revenue and a 4% increase in EBITDA, excluding impacts from divestitures [5][6] - Anticipated challenges include a $20 million-$30 million impact from the expiration of enhanced premium tax credits and potential fluctuations in consumer confidence affecting volume growth [5][6][9] Market Trends and Volume Expectations - The company expects low single-digit volume growth in 2026, with consumer confidence being a critical factor [9][10][11] - CHS's markets have median incomes approximately 18% lower than the national average, influencing healthcare-seeking behavior [11] Revenue Drivers - Revenue per adjusted admission is expected to increase primarily due to rate increases, with Medicare inpatient rates rising by 4% and managed care contracts by 3%-5% [12] Health Insurance Exchange (HIX) Impact - HIX contributes less than 5% to CHS's volumes and revenues, with an estimated negative EBITDA impact of $20 million-$30 million anticipated [13][14] State Directed Payments - Updates on State Directed Payments indicate that Georgia has been approved, with expected EBITDA impacts of $10 million-$15 million. Florida is awaiting formal announcement [17][18] Medicaid Cuts - Initial Medicaid cuts are expected to have minimal impact in 2027, with significant cuts projected for 2028, potentially affecting $70 million-$80 million [19] Cost Management - Labor costs are projected to increase by 3%-4% in 2026, with contract labor normalizing [23] - Supply costs are expected to remain stable due to long-term contracts and a significant portion of domestic supplies [24] ERP System and AI Utilization - The new ERP system has saved approximately $50 million in the past year, with expectations for continued savings and efficiencies through AI integration [27][30] Capital Structure and Leverage - CHS aims to reduce leverage to a midterm target of 5.5 times, with ongoing divestitures and improved cash flows supporting this goal [32][33] - The company is focusing on growth-related capital projects, particularly in outpatient services [37] Cash Flow Expectations - Free cash flow for 2025 was $150 million, with a projected headwind of $140 million in 2026 due to an additional pay period [39][40] Investor Insights - CHS emphasizes its path to lower leverage and positive free cash flow, which is not yet reflected in stock price [41][42] - The company anticipates tailwinds from the Rural Health Transformation Fund and state-directed payment programs [43] Additional Considerations - The company is in early-stage discussions for potential divestitures but is cautious about selling assets with greater growth potential [34] - CHS is monitoring the impact of macroeconomic factors on its operations and financial performance [24][25]